• 제목/요약/키워드: Endoscopy, gastrointestinal

검색결과 565건 처리시간 0.033초

시멘트 경화제 중독으로 인한 급성 신손상 1례 (A Case of Cement Hardening Agent Intoxication with Acute Kidney Injury)

  • 서영우;장태창;김균무;고승현
    • 대한임상독성학회지
    • /
    • 제16권2호
    • /
    • pp.157-160
    • /
    • 2018
  • Chronic silica nephropathy has been associated with tubulointerstitial disease, immune-mediated multisystem disease, chronic kidney disease, and end-stage renal disease. On the other hand, acute intentional exposure is extremely rare. The authors' experienced a 44-year-old man who took rapid cement hardener (sodium silicate) in a suicide attempt whilst in a drunken state. He visited the emergency department approximately 1 hour after ingestion. Information on the material was obtained after 3 L gastric lavage. The patient complained of a sore throat, epigastric pain, and swollen to blood tinged vomitus. Proton pump inhibitors, hemostats, steroid, and fluids were administered. Nine hours after ingestion, he was administered 200 mL hematochezia. Immediately after, a gas-troenterologist performed an endoscopic procedure that revealed diffuse hyperemic mucosa with a color change and variable sized ulceration in the esophagus, whole stomach, and duodenal $2^{nd}$ portion. Approximately 35 hours later, persistent oligouria and progressive worsening of the renal function parameters (BUN/Cr from 12.2/1.2 to 67.5/6.6 mg/dL) occurred requiring hemodialysis. The patient underwent 8 sessions of hemodialysis for 1 month and the BUN/Cr level increased to 143.2/11.2 mg/dL and decreased to 7.6/1.5 mg/dL. He was discharged safely from the hospital. Follow up endoscopy revealed a severe esophageal stricture and he underwent endoscopic bougie dilatation. Acute cement hardener (sodium silicate) intoxication can cause renal failure and strong caustic mucosal injury. Therefore, it is important to consider early hemodialysis and treatment to prevent gastrointestinal injury and remote esophageal stricture.

Bleeding After Gastric Endoscopic Submucosal Dissection Focused on Management of Xa Inhibitors

  • Ono, Shoko;Ieko, Masahiro;Tanaka, Ikko;Shimoda, Yoshihiko;Ono, Masayoshi;Yamamoto, Keiko;Sakamoto, Naoya
    • Journal of Gastric Cancer
    • /
    • 제22권1호
    • /
    • pp.47-55
    • /
    • 2022
  • Purpose: The use of direct oral Xa inhibitors (DXaIs) to prevent venothrombotic events is increasing. However, gastrointestinal bleeding, including that related to endoscopic resection, is a concern. In this study, we evaluated bleeding and coagulation times during the perioperative period of gastric endoscopic submucosal dissection (ESD). Materials and Methods: Patients who consecutively underwent gastric ESD from August 2016 to December 2018 were analyzed. Bleeding rates were compared among the 3 groups (antiplatelet, DXaIs, and control). DXaI administration was discontinued on the day of the procedure. Prothrombin time (PT), activated partial thromboplastin time, and the ratio of inhibited thrombin generation (RITG), which was based on dilute PT, were determined before and after ESD. Results: During the study period, 265 gastric ESDs were performed in 239 patients, where 23 and 50 patients received DXaIs and antiplatelets, respectively. Delayed bleeding occurred in 17 patients (7.4%) and 21 lesions (7.1%). The bleeding rate in the DXaI group was significantly higher than that in the other groups (30.4%, P<0.01), and the adjusted odds ratio of bleeding was 5.7 (95% confidence interval, 1.4-23.7; P=0.016). In patients using DXaIs, there was a significant (P=0.046) difference in the median RITG between bleeding cases (18.6%) and non-bleeding cases (3.8%). Conclusions: A one-day cessation of DXaIs was related to a high incidence of bleeding after gastric ESD, and monitoring of residual coagulation activity at trough levels might enable the predicted risk of delayed bleeding in patients using DXaIs.

Clinical Features of Eosinophilic Esophagitis: A Single Center Experience in Ecuador

  • Munoz, Fabian Vasconez;Almeida, Pamela Hernandez;Carrion-Jaramillo, Estefania;Montalvo, Andrea Vasconez
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제25권4호
    • /
    • pp.293-299
    • /
    • 2022
  • Purpose: Data on eosinophilic esophagitis (EoE) in South America is scarce. Moreover, no studies are available in Ecuador. We evaluated the clinical, endoscopic, and histological characteristics of Ecuadorian children with EoE. Methods: Medical records of 2,711 children who underwent upper gastrointestinal endoscopy (UGE) between 2009 and 2020 at Hospital Metropolitano de Quito, Ecuador were reviewed. Esophageal mucosal biopsies were obtained from 72 patients and the features of 35 children with EoE were described. EoE was diagnosed when there were more than 15 eosinophils in the esophagus, per high power field. Results: EoE was diagnosed in 35 children (9.4±4.5 years) with a male predominance (74%). Abdominal pain (51.4%) and vomiting (31.4%) were dominant symptoms. A history of allergic diseases was noted in 47.1% of the children, which mainly included allergic rhinitis (37.1%) and atopic dermatitis (11.4%). The most common endoscopic findings were furrowing (82.9%) and edema (74.3%). All patients were initially treated with proton-pump inhibitors (PPIs). Those who did not respond to PPIs received steroids (5.7%) and diet therapy (5.7%), and five patients were referred to an allergist. Clinical and histological resolution was observed in 65% of the patients who underwent a second UGE after 6-8 weeks of PPI. Conclusion: Our study describes the clinical features of pediatric EoE in Ecuador. This is the first retrospective study in Ecuador that describes the clinical, endoscopic, and histological manifestations of EoE in a small pediatric population. Almost half of the children who underwent a biopsy had EoE.

Impact of the COVID-19 Pandemic on Gastric Cancer Screening in South Korea: Results From the Korean National Cancer Screening Survey (2017-2021)

  • Lee, Kyeongmin;Suh, Mina;Jun, Jae Kwan;Choi, Kui Son
    • Journal of Gastric Cancer
    • /
    • 제22권4호
    • /
    • pp.264-272
    • /
    • 2022
  • Purpose: The coronavirus disease 2019 (COVID-19) pandemic has significantly disrupted cancer screening services worldwide. We aimed to measure the impact of COVID-19 on gastric cancer screening rates based on age, sex, household income, and residential area. Materials and Methods: We analyzed data from the Korean National Cancer Screening Survey from 2017 to 2021 for adults aged 40-74 years. We evaluated the gastric cancer screening rate within two years in accordance with the National Cancer Screening Program protocol recommendations and that within the previous year. We compared the trends in the pre- and post-COVID-19 outbreak periods. Results: Before the COVID-19 outbreak, there was little change in the gastric cancer screening rates until 2019. After the COVID-19 outbreak, the screening rate as per recommendation decreased from 70.8% in 2019 to 68.9% in 2020 and that for one year decreased from 32.7% in 2019 to 27.2% in 2020. However, as the COVID-19 pandemic continued after 2020, both gastric cancer screening rates as per recommendations and for one year rebounded. Although a similar trend was observed for the upper endoscopy screening rate, the upper gastrointestinal series screening rate decreased from 7.8% in 2020 to 3.1% in 2021. During the pandemic, the screening rate decreased among younger adults (40-49), those residing in metropolitan regions, and those with high incomes. Conclusions: Despite a decline in gastric cancer screening rate during the COVID-19 pandemic, the rate surged in 2021. Further studies are needed to estimate the impact of cancer screening delays on future cancer-related mortalities.

림프절 전이가 동반된 진행성 위암 환자에서 수술 전 항암요법으로 시행한 FOLFOX 치료로 완전 관해를 보인 1례 (A Case of Complete Response with FOLFOX Based Neo-adjuvant Chemotherapy in Advanced Gastric Cancer with Lymph Node Metastasis)

  • 김명희;정현용;문희석;성재규;강선형;김주석
    • Journal of Digestive Cancer Research
    • /
    • 제6권1호
    • /
    • pp.40-44
    • /
    • 2018
  • 국소적인 진행성 위암의 근치적인 치료는 수술이 첫 번째 방법이다. 하지만 위암을 진단받은 환자 중에서 약 30% 만이 수술이 가능한 진행성 위암으로 진단을 받으며 그 중 약 40-60% 만이 R0 절제술이 가능하다. 저자들은 위 주위 림프절과 복강 림프절, 장막을 침범한 진행성 위암을 진단받은 환자를 3주간의 수술 전 항암화학요법으로 치료하였고, 근치적인 목적으로 위 절제술을 시행하였다. 조직병리검사에서 완전히 괴사된 종양 조직을 관찰할 수 있었고, 수술 후 현재까지 3차례의 추가적인 전신 항암화학요법을 시행하고 있으며, 추적 복부 전산화단층촬영에서 재발을 시사하는 소견을 보이지 않았다.

  • PDF

코일을 이용한 역행성 경정맥 폐색술에 의한 십이지장 정맥류 출혈의 성공적 치료: 증례 보고 (Successful Treatment of Duodenal Variceal Bleeding with Coil-Assisted Retrograde Transvenous Obliteration: A Case Report)

  • 박세진;김영환;강웅래;지승우
    • 대한영상의학회지
    • /
    • 제81권1호
    • /
    • pp.231-236
    • /
    • 2020
  • 십이지장 정맥류는 간경화증에 의한 문맥압 고혈압 환자에서 발생할 수 있으며, 치명적인 심한 상부 위장관 출혈을 일으킬 수 있으나 아직까지 명확한 치료 지침이 정립되어 있지는 않다. 일차적으로 내시경으로 치료를 시도하고 지혈 실패 시 목정맥경유간속문맥전신순환연결술, 풍선 혹은 혈관 마개를 이용한 역행성 경정맥 폐색술, 피부간경유 폐색술 등과 같은 중재적 치료를 고려할 수 있다. 저자들은 내시경적 치료에 실패한 십이지장 정맥류 출혈 환자에게 저하된 간 기능과 해부학적인 구조의 제한으로 인해 코일을 이용한 역행성 경정맥 폐색술을 시행하여 성공적으로 치료한 1예를 경험하였기에 이를 보고하고자 한다.

Unconventional shunt surgery for non-cirrhotic portal hypertension in patients not suitable for proximal splenorenal shunt

  • Harilal, S L;Biju Pottakkat;Senthil Gnanasekaran;Kalayarasan Raja
    • 한국간담췌외과학회지
    • /
    • 제27권3호
    • /
    • pp.264-270
    • /
    • 2023
  • Backgrounds/Aims: Proximal splenorenal shunt (PSRS) is a commonly performed procedure to decompress portal hypertension, in patients with refractory variceal bleed, especially in non-cirrhotic portal hypertension (NCPH). If conventional methods are hindered by any technical or pathological factors, alternative surgical techniques may be required. This study analyzes the effectiveness of various unconventional shunt surgeries performed for NCPH. Methods: A retrospective analysis of NCPH patients who underwent unconventional shunt surgeries during the period July 2011 to June 2022 was conducted. All patients were followed up for a minimum of 12 months with doppler study of the shunt to assess shunt patency, and upper gastrointestinal endoscopy to evaluate the regression of varices. Results: During the study period, 130 patients underwent shunt surgery; among these, 31 underwent unconventional shunts (splenoadrenal shunt [SAS], 12; interposition mesocaval shunt [iMCS], 8; interposition PSRS [iPSRS], 6; jejunal vein-cava shunt [JCS], 3; left gastroepiploic-renal shunt [LGERS], 2). The main indications for unconventional shunts were left renal vein aberration (SAS, 8/12), splenic vein narrowing (iMCS, 5/8), portalhypertensive vascular changes (iPSRS, 6/6), and portomesenteric thrombosis (JCS, 3/3). The median fall in portal pressure was more in SAS (12.1 mm Hg), and operative time more in JCS, 8.4 hours (range, 5-9 hours). During a median follow-up of 36 months (6-54 months), shunt thrombosis had been reported in all cases of LGERS, and less in SAS (3/12). Variceal regression rate was high in SAS, and least in LGERS. Hypersplenism had reversed in all patients, and 6/31 patients had a recurrent bleed. Conclusions: Unconventional shunt surgery is effective in patients unsuited for other shunts, especially PSRS, and it achieves the desired effects in a significant proportion of patients.

내시경 점막 절제술로 진단 및 치료했던 위바닥샘형 선암 (Gastric Adenocarcinoma of Fundic-gland Type Diagnosed and Treated by Endoscopic Mucosal Resection)

  • 김성은;박선자;박무인;문원;김재현;정경원;김방주;장희경
    • Journal of Digestive Cancer Research
    • /
    • 제11권3호
    • /
    • pp.165-170
    • /
    • 2023
  • Gastric cancer is histologically classified into two types. One is the intestinal and diffuse type according to Lauren's classification, and the other is the differentiated and undifferentiated type based on Nakamura's classification. In 2007, Japanese groups proposed a new type of well-differentiated gastric adenocarcinoma in the gastric fundic glands with distinct endoscopic and clinicopathologic features. This is gastric adenocarcinoma of the fundic-gland type (GA-FG), a rare variant of gastric cancer. In a 2012 Korean study, of 6,000 cases of gastric cancer tissues, only three cases of GA-FG were identified. GA-FG is usually located in the upper third of the stomach and not known to be associated with the Helicobacter pylori infection. We herein report a case of GA-FG diagnosed in a 63-year-old man. A gastric polyp was incidentally detected during an upper endoscopy screening while conducting a health check-up, and he was diagnosed with GA-FG after an endoscopic mucosal resection (EMR) was conducted for diagnostic and therapeutic purposes. Our case suggests that for both diagnostic and therapeutic purposes, EMR may be beneficial in case of gastric polyps with suspected GA-FG.

Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach

  • Tae-Han Kim;In-Ho Kim;Seung Joo Kang;Miyoung Choi;Baek-Hui Kim;Bang Wool Eom;Bum Jun Kim;Byung-Hoon Min;Chang In Choi;Cheol Min Shin;Chung Hyun Tae;Chung sik Gong;Dong Jin Kim;Arthur Eung-Hyuck Cho;Eun Jeong Gong;Geum Jong Song;Hyeon-Su Im;Hye Seong Ahn;Hyun Lim;Hyung-Don Kim;Jae-Joon Kim;Jeong Il Yu;Jeong Won Lee;Ji Yeon Park;Jwa Hoon Kim;Kyoung Doo Song;Minkyu Jung;Mi Ran Jung;Sang-Yong Son;Shin-Hoo Park;Soo Jin Kim;Sung Hak Lee;Tae-Yong Kim;Woo Kyun Bae;Woong Sub Koom;Yeseob Jee;Yoo Min Kim;Yoonjin Kwak;Young Suk Park;Hye Sook Han;Su Youn Nam;Seong-Ho Kong;The Development Working Group for the Korean Practice Guidelines for Gastric Cancer 2022 Task Force Team
    • Journal of Gastric Cancer
    • /
    • 제23권1호
    • /
    • pp.3-106
    • /
    • 2023
  • Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this is the 4th gastric cancer guideline published in Korea which is the revised version of previous evidence-based approach in 2018. Current guideline is a collaborative work of the interdisciplinary working group including experts in the field of gastric surgery, gastroenterology, endoscopy, medical oncology, abdominal radiology, pathology, nuclear medicine, radiation oncology and guideline development methodology. Total of 33 key questions were updated or proposed after a collaborative review by the working group and 40 statements were developed according to the systematic review using the MEDLINE, Embase, Cochrane Library and KoreaMed database. The level of evidence and the grading of recommendations were categorized according to the Grading of Recommendations, Assessment, Development and Evaluation proposition. Evidence level, benefit, harm, and clinical applicability was considered as the significant factors for recommendation. The working group reviewed recommendations and discussed for consensus. In the earlier part, general consideration discusses screening, diagnosis and staging of endoscopy, pathology, radiology, and nuclear medicine. Flowchart is depicted with statements which is supported by meta-analysis and references. Since clinical trial and systematic review was not suitable for postoperative oncologic and nutritional follow-up, working group agreed to conduct a nationwide survey investigating the clinical practice of all tertiary or general hospitals in Korea. The purpose of this survey was to provide baseline information on follow up. Herein we present a multidisciplinary-evidence based gastric cancer guideline.

진단 전에 자반이 동반되지 않았던 Henoch-Schönlein 자반 위장병증의 임상적 고찰 (Clinical Features of Henoch-Schönlein Purpura Gastroenteropathy without Purpura before Diagnosis)

  • 오재민;박재홍
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제7권1호
    • /
    • pp.54-60
    • /
    • 2004
  • 목 적: Henoch-Schonlein 자반증(HSP)은 비혈소판 감소성 피부 병변, 관절통 및 관절염, 신 질환, 산통성 복통이 특징적인 소혈관의 혈관 염증성 질환이다. 피부가 가장 흔히 침범되며 환자의 14~36%에서는 특징적 피부 자반이 나타나기 전에 복부 증상이 나타난다고 알려져 있다. 최근 들어 피부 발진이 없이 복통으로 발현되는 HSP에 대한 보고가 있으나, 아직까지 진단에 많은 어려움이 있으며 보다 체계적인 연구가 필요할 것으로 사료되어 본 연구를 시행하였다. 방 법: 1995년에서 2000년까지 HSP로 진단된 환아 85명을 대상으로 진단 전 피부 병변이 없었던 군(자반 음성군)과 있었던 군(자반 양성군)으로 구분하고 병력지를 근거로 후향적 조사 및 일부 검사에 대한 전향적 연구를 시행하였다. 결 과: 자반 양성군이 72명, 자반 음성군이 10명이었다. 자반 양성군의 경우 평균 연령 6.84세, 남녀비 1.25 : 1이었고, 자반 음성군의 경우는 평균 연령 7.07세, 남녀비 1 : 1이었다. 일반 혈액학적 검사에서 백혈구 증다증이나 혈소판 증가증의 빈도는 두 군 사이에 통계학적인 차이를 보이지 않았다(p value>0.05). C-염증성 단백의 증가는 자반 양성군에서 54.8% (34명), 자반 음성군에서 42.9% (3명)로 두 군 사이에 의미 있는 차이가 없었다(p value>0.05). 복부 증상의 경우 오심, 구토 등은 자반 음성군에서 8명(80%), 자반 양성군에서 27명(36%)으로 자반 음성군이 높은 빈도를 나타내었으나(p value=0.01), 흑색변이나 혈변과 같은 위장관 출혈을 보인 경우는 자반 양성군에서 21명(29.2%), 자반 음성군에서 4명(40%)으로 두 군 사이에 통계학적인 차이가 없었다. 관절 증상이나 신 침범의 동반 빈도도 양군에서 차이를 보이지 않아 자반을 제외한 임상 양상은 두 군이 서로 비슷했다. 자반 음성군의 경우 복부 초음파 검사 및 소장 조영술에서 소장 점막의 비후로 인한 변화가 관찰되었고, 상부 위장관 내시경을 시행한 8명 중, 6명에서 융합성의 미란성 발적, 부종, 다발성 선상 궤양, 보라빛 변색 등이 위 전정부 또는 십이지장 구부나 둘째부에서 관찰되었다. 2명에서는 대장 내시경 검사를 시행, 1명에서 직장강 내에 미란성의 병변을 확인하였다. 3명의 환아를 대상으로 정상 피부에서 조직 검사를 시행하였는데 백혈구 파괴성 혈관염에 합당한 소견을 보였다. 자반 음성군 환아 10명 중 9명에서 스테로이드를 경구 또는 정주하여 증상의 호전을 보였으며 1명에서는 단순 진통제만으로 증상 경감을 보였다. 결 론: 진단 시 자반이 없었던 경우 일반적인 검사에서는 진단적 소견이 없었으나, 위장관 내시경 검사에서 HSP 위장병증에 합당한 소견이 관찰되거나 복부 초음파 검사 또는 소장 조영술 검사에서 장벽의 변화, 피부 또는 신장 조직 검사에서 백혈구 파괴성 혈관염이 입증될 경우 진단이 가능할 것으로 사료된다.

  • PDF